AIPortalGlobal is the corporate parent of three AI-native vertical-SaaS pillars operating in Mexico and Canada. Bootstrap-financed, family-founded, and structured as a portfolio of independently marketable brands — each with its own domain, trademark strategy, regulatory footprint, and potential exit path.
Each pillar operates as an independently marketable brand with its own domain, trademark filings, target buyers, regulatory footprint, and — ultimately — its own potential exit path. A governance discipline typical of mature vertical-SaaS holdings, providing strategic optionality to license, spin off, or divest any single pillar without affecting the others.
Dental vertical — general dentistry, orthodontics, endodontics, periodontology. IMPI trademark registration in progress. Canadian launch pillar.
Veterinary vertical — companion animals, small animal practice. Dr. Orejas™ registered brand asset. IAPortalVet™ (Exp. 3648596) + Dr. Orejas™ IMPI registered. Canadian launch pillar.
Human medicine vertical — general practice, specialists. AIPortalMed™ IMPI registered (Exp. 3580156). Mexico-first commercial strategy; Canadian expansion evaluated post-Year 3, subject to Health Canada regulatory clearance.
A summary of the corporate group's operating footprint, financial profile, and regulatory posture.
Why AIPortalGlobal's positioning is defensible against horizontal EMR incumbents in the short term and attractive to strategic acquirers in the long term.
Google Gemini Vision for diagnostic assistance, AI Scribe for SOAP notes, curated medication-interaction engines, and predictive no-show alerts — built into the platform, not bolted on.
Each pillar is a purpose-built product for its clinical vertical — with its own compliance frameworks, its own workflows, and its own buyer archetypes. No 'one-size-fits-all' horizontal EMR pretending to serve every profession.
The founding family finances the entire operation with proven professional capital. No external investors, no board pressure, no growth-at-all-costs mandate. Decisions are made at family speed with founder discipline — a governance profile that Canadian Designated Organizations value highly.
Architected from the ground up for both Mexican and Canadian regulatory environments. NOM-024, NOM-013, NOM-064, LFPDPPP in Mexico; PIPEDA, Loi 25, PIPA, provincial regulatory frameworks in Canada. Not an American product retrofitted for other jurisdictions.
A governance profile designed for long-horizon institutional trust, not short-horizon growth-at-all-costs pressure.
The founding family self-finances the entire operation through founder pension income, established Canadian banking relationships with Scotiabank Canada, and projected professional translation income. Total upfront Canadian capital requirement of CAD 130,000–155,000 fully covered without external funding round. No convertible notes, no SAFEs, no equity dilution.
Two founding executives — the founder (CEO) and his spouse (COO), together carrying more than fifty combined years of regulated-industry experience at NCR, BBVA, Monex, Siemens, Gillette, and Prudential Mexico. Founding equity is family-held. Governance decisions are made at family speed with founder discipline — a profile that Canadian Designated Organizations and long-horizon institutional partners value highly.
Trademarks registered with the Mexican Institute of Industrial Property (IMPI): AIPortalMed™ (Exp. 3580156), IAPortalVet™ (Exp. 3648596), Dr. Orejas™. AIPortalGlobal™ and AIPortalDent™ trademark registrations in progress. Canadian trademark filings (CIPO) planned concurrent with AIPortalCanada Inc. incorporation. Defensive registration strategy for all four .mx country-code domains.
Weekly automated Git bundle backups to OneDrive for all three product codebases. Cloud Run + Cloud SQL PostgreSQL production environment on Google Cloud Platform with continuous integration, monitoring, and automated backups. Corporate email through Resend + Cloudflare on aiportalmed.com. Written business continuity plan addressing single-founder key-person risk.
Thirty+ years in enterprise systems at NCR Corporation, BBVA Bancomer, and Monex Grupo Financiero. Cybernetics and Systems Computing Engineering + MBA from EGADE Business School, Tec de Monterrey — the top-ranked business school in Latin America. Founder, architect, and sole financier of the AIPortalGlobal platform group.
Communications degree with 20+ years of enterprise corporate experience as Network Manager at Siemens, Gillette, and Prudential Mexico. Advanced professional English proficiency. Leads customer success, bilingual content development, and cross-border administrative oversight across Mexican and Canadian operations.
AIPortalGlobal's products are classified as practice management software — administrative, records, and workflow tooling that empowers licensed clinicians without substituting for clinical judgment. This scope is deliberate: it reflects both our product philosophy and a clear regulatory positioning outside the Medical Devices Regulation frameworks of Canada (Health Canada) and Mexico (COFEPRIS Medical Device classification).
A curated set of corporate documents available on request. Written to Canadian professional and Mexican regulatory standards. Provided under NDA for sensitive financial materials.
Overview brief prepared for Canadian Designated Organization and Winnipeg partner-firm review. Covers portfolio structure, founding team, financial resilience, and Start-Up Visa strategy.
Request the Brief →Full corporate documentation package: market analysis, product architecture, competitive positioning, five-year financial projections, hiring plan, tax contribution modeling, and go-to-market execution.
Request under NDA →Concise investor-grade pitch deck with speaker notes. Accompanying five-year financials (revenue, EBITDA, hiring plan) and a product differentiators deep-dive suitable for institutional review.
Request under NDA →This corporate address is monitored by the founder. It is the appropriate channel for Designated Organizations, legal partners, prospective investors, journalists, industry analysts, and acquirer representatives conducting preliminary review.
contacto@aiportalmed.com